Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
8.01
+2.00 (33.28%)
Mar 9, 2026, 3:36 PM EDT - Market open
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $346.63 million as of March 9, 2026. Its market cap has increased by 2,587.04% in one year.
Market Cap
346.63M
Enterprise Value
354.53M
1-Year Change
2,587.04%
Ranking
Category
Stock Price
$8.01
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $346.63M, an increase of 213.41%. That is a compound annual growth rate of 10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 42.00M | 49.47% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 273.64M |
| Coherus Oncology | 272.04M |
| Enlivex | 270.61M |
| Prelude Therapeutics | 266.14M |
| Cellectis | 265.08M |
| Fennec Pharmaceuticals | 262.98M |
| Abeona Therapeutics | 262.83M |
| Cybin | 262.69M |